Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
The Lancet. Haematology|July 2, 2022
Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trialFrank Cools, Saverio Virdone, Jitendra Sawhney, et al.
Plos One|October 30, 2016
Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF RegistrySylvia Haas, Hugo Ten Cate, Gabriele Accetta, et al.
American Heart Journal|May 26, 2019
Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AFSylvia Haas, A John Camm, Jean-Pierre Bassand, et al.
Plos One|July 11, 2024
Prevalence and risk factors of gastroesophageal reflux disease in Iran: A cross-sectional analysis from the PERSIAN cohortAnahita Sadeghi, Paria Boustani, Ali Mehrpour, et al.
Plos Medicine|June 21, 2022
Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trialSimbarashe Takuva, Azwidhwi Takalani, Ishen Seocharan, et al.
Blood Advances|August 20, 2024
Meta-analysis of genome-wide association studies of stable warfarin dose in patients of African ancestryInnocent G Asiimwe, Marc Blockman, Larisa H Cavallari, et al.
Thrombosis Research|August 25, 2023
Enoxaparin for symptomatic COVID-19 managed in the ambulatory setting: An individual patient level analysis of the OVID and ETHIC trialsStefano Barco, Saverio Virdone, Andrea Götschi, et al.
The Lancet. Infectious Diseases|December 18, 2020
SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional studyHossein Poustchi, Maryam Darvishian, Zahra Mohammadi, et al.
Lancet (London, England)|March 20, 2022
Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation studyLinda-Gail Bekker, Nigel Garrett, Ameena Goga, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 2021
Evaluation of the effect of sofosbuvir and daclatasvir in hospitalized COVID-19 patients: a randomized double-blind clinical trial (DISCOVER)Sara Mobarak, Mehdi Salasi, Ahmad Hormati, et al.
Pageof 12